Boceprevir Fluorinated sulfonamide HCV Molecular modeling Mutated NS3 protease Protein– ligand docking

Showing results in 'Publications'. Show all posts
Ezat, A., A. Elfiky, W. Elshemey, and N. Saleh, "Novel inhibitors against wild-type and mutated HCV NS3 serine protease: an in silico study", VirusDisease, vol. 30, pp. 207–213, 2019. ezat2019_article_novelinhibitorsagainstwild-typ.pdf